Avenciguat | Interleukin Related interleukin-related.com

Product Name :
Avenciguat

Search keywords :
Arbemnifosbuvir

drugId :
null

Target Vo:
Soluble guanylate cyclase

Target Vo Short Name :
sGC

Moa_Name:
Soluble guanylate cyclase activators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
C.H. Boehringer Sohn Ag & Co. Kg

Active Company_Name :
Almac Pharma Services Ltd

Active Indication_Name:
Scleroderma, Systemic

In Active Indication_Name:
Ascites

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Aurora B Rabbit mAb In Vivo
SIRT3 Rabbit mAb Epigenetics
EpCAM Antibody (YA458): EpCAM Antibody (YA458) is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to EpCAM. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts